華能國際(600011.SH):與香港財資公司擬共設曹妃甸清能公司 以開發華能十里海100兆瓦複合型光伏發電項目
格隆匯12月29日丨華能國際(600011.SH)公佈,公司全資子公司河北清能公司於2021年12月29日與香港財資公司簽署了《合資協議》,河北清能公司及香港財資公司共同出資設立曹妃甸清能公司。河北清能公司將出資人民幣11961.6萬元,香港財資公司將出資5126.4萬元人民幣等值美元。此次交易完成後,河北清能公司持有曹妃甸清能公司70%的權益,香港財資公司持有曹妃甸清能公司30%的權益。
曹妃甸清能公司由河北清能公司與香港財資公司共同出資設立,以開發華能十里海100兆瓦複合型光伏發電項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.